Keywords
Last Name
Institution

Ivo Kalajzic MD, PhD

TitleAssistant Professor
InstitutionUConn Health Center
DepartmentReconstructive Sciences
AddressMC 3705
MC 3705
263 Farmington Avenue
Phone860-679-6051
Fax860-679-2910
vCardDownload vCard
    Other Positions
    TitleAssistant Professor
    InstitutionUConn Health Center
    DepartmentGenetics and Developmental Biology


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Matthews BG, Torreggiani E, Roeder E, Matic I, Grcevic D, Kalajzic I. Osteogenic potential of alpha smooth muscle actin expressing muscle resident progenitor cells. Bone. 2016 Mar; 84:69-77. PMID: 26721734.
      View in: PubMed
    2. Sagomonyants K, Kalajzic I, Maye P, Mina M. Enhanced Dentinogenesis of Pulp Progenitors by Early Exposure to FGF2. J Dent Res. 2015 Nov; 94(11):1582-90. PMID: 26276371; PMCID: PMC4622321 [Available on 11/01/16].
    3. Matthews BG, Roguljic H, Franceschetti T, Roeder E, Matic I, Vidovic I, Joshi P, Kum KY, Kalajzic I. Gene-expression analysis of cementoblasts and osteoblasts. J Periodontal Res. 2016 Jun; 51(3):304-12. PMID: 26215316.
      View in: PubMed
    4. Kolind M, Bobyn JD, Matthews BG, Mikulec K, Aiken A, Little DG, Kalajzic I, Schindeler A. Lineage tracking of mesenchymal and endothelial progenitors in BMP-induced bone formation. Bone. 2015 Dec; 81:53-9. PMID: 26141839.
      View in: PubMed
    5. Prater MD, Petit V, Alasdair Russell I, Giraddi RR, Shehata M, Menon S, Schulte R, Kalajzic I, Rath N, Olson MF, Metzger D, Faraldo MM, Deugnier MA, Glukhova MA, Stingl J. Mammary stem cells have myoepithelial cell properties. Nat Cell Biol. 2014 Oct; 16(10):942-50, 1-7. PMID: 25173976; PMCID: PMC4183554.
    6. Krevvata M, Silva BC, Manavalan JS, Galan-Diez M, Kode A, Matthews BG, Park D, Zhang CA, Galili N, Nickolas TL, Dempster DW, Dougall W, Teruya-Feldstein J, Economides AN, Kalajzic I, Raza A, Berman E, Mukherjee S, Bhagat G, Kousteni S. Inhibition of leukemia cell engraftment and disease progression in mice by osteoblasts. Blood. 2014 Oct 30; 124(18):2834-46. PMID: 25139351; PMCID: PMC4314530.
    7. Dyment NA, Hagiwara Y, Matthews BG, Li Y, Kalajzic I, Rowe DW. Lineage tracing of resident tendon progenitor cells during growth and natural healing. PLoS One. 2014; 9(4):e96113. PMID: 24759953; PMCID: PMC3997569.
    8. Zanotti S, Kalajzic I, Aguila HL, Canalis E. Sex and genetic factors determine osteoblastic differentiation potential of murine bone marrow stromal cells. PLoS One. 2014; 9(1):e86757. PMID: 24489784; PMCID: PMC3904935.
    9. Pauley P, Matthews BG, Wang L, Dyment NA, Matic I, Rowe DW, Kalajzic I. Local transplantation is an effective method for cell delivery in the osteogenesis imperfecta murine model. Int Orthop. 2014 Sep; 38(9):1955-62. PMID: 24384938; PMCID: PMC4382010.
    10. Li X, Garcia J, Lu J, Iriana S, Kalajzic I, Rowe D, Demer LL, Tintut Y. Roles of parathyroid hormone (PTH) receptor and reactive oxygen species in hyperlipidemia-induced PTH resistance in preosteoblasts. J Cell Biochem. 2014 Jan; 115(1):179-88. PMID: 24038594; PMCID: PMC3889484.
    11. Matthews BG, Grcevic D, Wang L, Hagiwara Y, Roguljic H, Joshi P, Shin DG, Adams DJ, Kalajzic I. Analysis of aSMA-labeled progenitor cell commitment identifies notch signaling as an important pathway in fracture healing. J Bone Miner Res. 2014; 29(5):1283-94. PMID: 24190076.
      View in: PubMed
    12. Torreggiani E, Matthews BG, Pejda S, Matic I, Horowitz MC, Grcevic D, Kalajzic I. Preosteocytes/osteocytes have the potential to dedifferentiate becoming a source of osteoblasts. PLoS One. 2013; 8(9):e75204. PMID: 24040401; PMCID: PMC3765403.
    13. Repic D, Torreggiani E, Franceschetti T, Matthews BG, Ivcevic S, Lichtler AC, Grcevic D, Kalajzic I. Utilization of transgenic models in the evaluation of osteogenic differentiation of embryonic stem cells. Connect Tissue Res. 2013; 54(4-5):296-304. PMID: 23782451; PMCID: PMC3893759.
    14. Yang W, Guo D, Harris MA, Cui Y, Gluhak-Heinrich J, Wu J, Chen XD, Skinner C, Nyman JS, Edwards JR, Mundy GR, Lichtler A, Kream BE, Rowe DW, Kalajzic I, David V, Quarles DL, Villareal D, Scott G, Ray M, Liu S, Martin JF, Mishina Y, Harris SE. Bmp2 in osteoblasts of periosteum and trabecular bone links bone formation to vascularization and mesenchymal stem cells. J Cell Sci. 2013 Sep 15; 126(Pt 18):4085-98. PMID: 23843612; PMCID: PMC3772385.
    15. Roguljic H, Matthews BG, Yang W, Cvija H, Mina M, Kalajzic I. In vivo identification of periodontal progenitor cells. J Dent Res. 2013 Aug; 92(8):709-15. PMID: 23735585; PMCID: PMC3711570.
    16. Jastrzebski S, Kalinowski J, Stolina M, Mirza F, Torreggiani E, Kalajzic I, Won HY, Lee SK, Lorenzo J. Changes in bone sclerostin levels in mice after ovariectomy vary independently of changes in serum sclerostin levels. J Bone Miner Res. 2013 Mar; 28(3):618-26. PMID: 23044658; PMCID: PMC3554870.
    17. Matic I, Matthews BG, Kizivat T, Igwe JC, Marijanovic I, Ruohonen ST, Savontaus E, Adams DJ, Kalajzic I. Bone-specific overexpression of NPY modulates osteogenesis. J Musculoskelet Neuronal Interact. 2012 Dec; 12(4):209-18. PMID: 23196263; PMCID: PMC3558927.
    18. Kalajzic I, Matthews BG, Torreggiani E, Harris MA, Divieti Pajevic P, Harris SE. In vitro and in vivo approaches to study osteocyte biology. Bone. 2013 Jun; 54(2):296-306. PMID: 23072918; PMCID: PMC3566324.
    19. Grcevic D, Pejda S, Matthews BG, Repic D, Wang L, Li H, Kronenberg MS, Jiang X, Maye P, Adams DJ, Rowe DW, Aguila HL, Kalajzic I. In vivo fate mapping identifies mesenchymal progenitor cells. Stem Cells. 2012 Feb; 30(2):187-96. PMID: 22083974; PMCID: PMC3560295.
    20. Woo SM, Rosser J, Dusevich V, Kalajzic I, Bonewald LF. Cell line IDG-SW3 replicates osteoblast-to-late-osteocyte differentiation in vitro and accelerates bone formation in vivo. J Bone Miner Res. 2011 Nov; 26(11):2634-46. PMID: 21735478; PMCID: PMC3192242.
    21. Igwe JC, Gao Q, Kizivat T, Kao WW, Kalajzic I. Keratocan is expressed by osteoblasts and can modulate osteogenic differentiation. Connect Tissue Res. 2011 Oct; 52(5):401-7. PMID: 21405980; PMCID: PMC3574643.
    22. Liu Y, Wang L, Fatahi R, Kronenberg M, Kalajzic I, Rowe D, Li Y, Maye P. Isolation of murine bone marrow derived mesenchymal stem cells using Twist2 Cre transgenic mice. Bone. 2010 Nov; 47(5):916-25. PMID: 20673822; PMCID: PMC2952694.
    23. Li H, Jiang X, Delaney J, Franceschetti T, Bilic-Curcic I, Kalinovsky J, Lorenzo JA, Grcevic D, Rowe DW, Kalajzic I. Immature osteoblast lineage cells increase osteoclastogenesis in osteogenesis imperfecta murine. Am J Pathol. 2010 May; 176(5):2405-13. PMID: 20348238; PMCID: PMC2861105.
    24. Gooi JH, Pompolo S, Karsdal MA, Kulkarni NH, Kalajzic I, McAhren SH, Han B, Onyia JE, Ho PW, Gillespie MT, Walsh NC, Chia LY, Quinn JM, Martin TJ, Sims NA. Calcitonin impairs the anabolic effect of PTH in young rats and stimulates expression of sclerostin by osteocytes. Bone. 2010 Jun; 46(6):1486-97. PMID: 20188226.
      View in: PubMed
    25. Igwe JC, Jiang X, Paic F, Ma L, Adams DJ, Baldock PA, Pilbeam CC, Kalajzic I. Neuropeptide Y is expressed by osteocytes and can inhibit osteoblastic activity. J Cell Biochem. 2009 Oct 15; 108(3):621-30. PMID: 19670271; PMCID: PMC2754602.
    26. Dean AK, Harris SE, Kalajzic I, Ruan J. A systems biology approach to the identification and analysis of transcriptional regulatory networks in osteocytes. BMC Bioinformatics. 2009; 10 Suppl 9:S5. PMID: 19761575; PMCID: PMC2745692.
    27. Paic F, Igwe JC, Nori R, Kronenberg MS, Franceschetti T, Harrington P, Kuo L, Shin DG, Rowe DW, Harris SE, Kalajzic I. Identification of differentially expressed genes between osteoblasts and osteocytes. Bone. 2009 Oct; 45(4):682-92. PMID: 19539797; PMCID: PMC2731004.
    28. San Miguel SM, Fatahi MR, Li H, Igwe JC, Aguila HL, Kalajzic I. Defining a visual marker of osteoprogenitor cells within the periodontium. J Periodontal Res. 2010 Feb; 45(1):60-70. PMID: 19453851; PMCID: PMC2871067.
    29. Salie R, Li H, Jiang X, Rowe DW, Kalajzic I, Susa M. A rapid, nonradioactive in situ hybridization technique for use on cryosectioned adult mouse bone. Calcif Tissue Int. 2008 Sep; 83(3):212-21. PMID: 18762852.
      View in: PubMed
    30. Dallas SL, Veno PA, Rosser JL, Barragan-Adjemian C, Rowe DW, Kalajzic I, Bonewald LF. Time lapse imaging techniques for comparison of mineralization dynamics in primary murine osteoblasts and the late osteoblast/early osteocyte-like cell line MLO-A5. Cells Tissues Organs. 2009; 189(1-4):6-11. PMID: 18728354; PMCID: PMC2824180.
    31. Kalajzic Z, Li H, Wang LP, Jiang X, Lamothe K, Adams DJ, Aguila HL, Rowe DW, Kalajzic I. Use of an alpha-smooth muscle actin GFP reporter to identify an osteoprogenitor population. Bone. 2008 Sep; 43(3):501-10. PMID: 18571490; PMCID: PMC2614133.
    32. Li H, Marijanovic I, Kronenberg MS, Erceg I, Stover ML, Velonis D, Mina M, Heinrich JG, Harris SE, Upholt WB, Kalajzic I, Lichtler AC. Expression and function of Dlx genes in the osteoblast lineage. Dev Biol. 2008 Apr 15; 316(2):458-70. PMID: 18280462; PMCID: PMC2679944.
    33. Kalajzic I, Kalajzic Z, Wang L, Jiang X, Lamothe K, San Miguel SM, Aguila HL, Rowe DW. Pericyte/myofibroblast phenotype of osteoprogenitor cell. J Musculoskelet Neuronal Interact. 2007 Oct-Dec; 7(4):320-2. PMID: 18094492.
      View in: PubMed
    34. Nadiarnykh O, Plotnikov S, Mohler WA, Kalajzic I, Redford-Badwal D, Campagnola PJ. Second harmonic generation imaging microscopy studies of osteogenesis imperfecta. J Biomed Opt. 2007 Sep-Oct; 12(5):051805. PMID: 17994883.
      View in: PubMed
    35. Naganawa T, Xiao L, Abogunde E, Sobue T, Kalajzic I, Sabbieti M, Agas D, Hurley MM. In vivo and in vitro comparison of the effects of FGF-2 null and haplo-insufficiency on bone formation in mice. Biochem Biophys Res Commun. 2006 Jan 13; 339(2):490-8. PMID: 16298332.
      View in: PubMed
    36. Kalajzic I, Staal A, Yang WP, Wu Y, Johnson SE, Feyen JH, Krueger W, Maye P, Yu F, Zhao Y, Kuo L, Gupta RR, Achenie LE, Wang HW, Shin DG, Rowe DW. Expression profile of osteoblast lineage at defined stages of differentiation. J Biol Chem. 2005 Jul 1; 280(26):24618-26. PMID: 15834136.
      View in: PubMed
    37. Yang W, Lu Y, Kalajzic I, Guo D, Harris MA, Gluhak-Heinrich J, Kotha S, Bonewald LF, Feng JQ, Rowe DW, Turner CH, Robling AG, Harris SE. Dentin matrix protein 1 gene cis-regulation: use in osteocytes to characterize local responses to mechanical loading in vitro and in vivo. J Biol Chem. 2005 May 27; 280(21):20680-90. PMID: 15728181.
      View in: PubMed
    38. Lukic IK, Grcevic D, Kovacic N, Katavic V, Ivcevic S, Kalajzic I, Marusic A. Alteration of newly induced endochondral bone formation in adult mice without tumour necrosis factor receptor 1. Clin Exp Immunol. 2005 Feb; 139(2):236-44. PMID: 15654822; PMCID: PMC1809298.
    39. Yang W, Kalajzic I, Lu Y, Guo D, Harris MA, Gluhak-Heinrich J, Bonewald LF, Feng JQ, Rowe DW, Harris SE. In vitro and in vivo study on osteocyte-specific mechanical signaling pathways. J Musculoskelet Neuronal Interact. 2004 Dec; 4(4):386-7. PMID: 15758272.
      View in: PubMed
    40. Kalajzic I, Braut A, Guo D, Jiang X, Kronenberg MS, Mina M, Harris MA, Harris SE, Rowe DW. Dentin matrix protein 1 expression during osteoblastic differentiation, generation of an osteocyte GFP-transgene. Bone. 2004 Jul; 35(1):74-82. PMID: 15207743.
      View in: PubMed
    41. Katavic V, Grcevic D, Lukic IK, Vucenik V, Kovacic N, Kalajzic I, Marusic A. Non-functional Fas ligand increases the formation of cartilage early in the endochondral bone induction by rhBMP-2. Life Sci. 2003 Nov 21; 74(1):13-28. PMID: 14575809.
      View in: PubMed
    42. Rajan TV, Paciorkowski N, Kalajzic I, McGuiness C. Ascorbic acid is a requirement for the morphogenesis of the human filarial parasite Brugia malayi. J Parasitol. 2003 Aug; 89(4):868-70. PMID: 14533709.
      View in: PubMed
    43. Delany AM, Kalajzic I, Bradshaw AD, Sage EH, Canalis E. Osteonectin-null mutation compromises osteoblast formation, maturation, and survival. Endocrinology. 2003 Jun; 144(6):2588-96. PMID: 12746322.
      View in: PubMed
    44. Kalajzic I, Kalajzic Z, Hurley MM, Lichtler AC, Rowe DW. Stage specific inhibition of osteoblast lineage differentiation by FGF2 and noggin. J Cell Biochem. 2003 Apr 15; 88(6):1168-76. PMID: 12647299.
      View in: PubMed
    45. Kalajzic Z, Liu P, Kalajzic I, Du Z, Braut A, Mina M, Canalis E, Rowe DW. Directing the expression of a green fluorescent protein transgene in differentiated osteoblasts: comparison between rat type I collagen and rat osteocalcin promoters. Bone. 2002 Dec; 31(6):654-60. PMID: 12531558.
      View in: PubMed
    46. Kalajzic I, Terzic J, Rumboldt Z, Mack K, Naprta A, Ledgard F, Gronowicz G, Clark SH, Rowe DW. Osteoblastic response to the defective matrix in the osteogenesis imperfecta murine (oim) mouse. Endocrinology. 2002 May; 143(5):1594-601. PMID: 11956140.
      View in: PubMed
    47. Kalajzic I, Kalajzic Z, Kaliterna M, Gronowicz G, Clark SH, Lichtler AC, Rowe D. Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. J Bone Miner Res. 2002 Jan; 17(1):15-25. PMID: 11771662.
      View in: PubMed
    48. Braut A, Kalajzic I, Kalajzic Z, Rowe DW, Kollar EJ, Mina M. Col1a1-GFP transgene expression in developing incisors. Connect Tissue Res. 2002; 43(2-3):216-9. PMID: 12489162.
      View in: PubMed
    49. Visnjic D, Kalajzic I, Gronowicz G, Aguila HL, Clark SH, Lichtler AC, Rowe DW. Conditional ablation of the osteoblast lineage in Col2.3deltatk transgenic mice. J Bone Miner Res. 2001 Dec; 16(12):2222-31. PMID: 11760835.
      View in: PubMed
    50. Liu P, Kalajzic I, Stover ML, Rowe DW, Lichtler AC. Human bone marrow stromal cells are efficiently transduced by vesicular stomatitis virus-pseudotyped retrovectors without affecting subsequent osteoblastic differentiation. Bone. 2001 Oct; 29(4):331-5. PMID: 11595615.
      View in: PubMed
    51. Primorac D, Rowe DW, Mottes M, Barisic I, Anticevic D, Mirandola S, Gomez Lira M, Kalajzic I, Kusec V, Glorieux FH. Osteogenesis imperfecta at the beginning of bone and joint decade. Croat Med J. 2001 Aug; 42(4):393-415. PMID: 11471191.
      View in: PubMed
    52. Dacic S, Kalajzic I, Visnjic D, Lichtler AC, Rowe DW. Col1a1-driven transgenic markers of osteoblast lineage progression. J Bone Miner Res. 2001 Jul; 16(7):1228-36. PMID: 11450698.
      View in: PubMed
    53. Kalajzic I, Stover ML, Liu P, Kalajzic Z, Rowe DW, Lichtler AC. Use of VSV-G pseudotyped retroviral vectors to target murine osteoprogenitor cells. Virology. 2001 May 25; 284(1):37-45. PMID: 11352666.
      View in: PubMed
    54. Stover ML, Wang CK, McKinstry MB, Kalajzic I, Gronowicz G, Clark SH, Rowe DW, Lichtler AC. Bone-directed expression of Col1a1 promoter-driven self-inactivating retroviral vector in bone marrow cells and transgenic mice. Mol Ther. 2001 Apr; 3(4):543-50. PMID: 11319916.
      View in: PubMed
    55. Marusic A, Grcevic D, Katavic V, Kovacic N, Lukic IK, Kalajzic I, Lorenzo JA. Role of B lymphocytes in new bone formation. Lab Invest. 2000 Nov; 80(11):1761-74. PMID: 11092536.
      View in: PubMed
    56. Miric D, Rumboldt Z, Gancevic I, Eterovic D, Capkun V, Bozic I, Vukovic I, Kalajzic I. [Dynamic aggregation of thrombocytes in acute myocardial infarct]. Lijec Vjesn. 1996 Sep; 118(9):198-201. PMID: 9011739.
      View in: PubMed
    Kalajzic's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _